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Thís thesis describes the ciinical applicabil ity of the clivalent unchelated
r l d i on t r c l i dc  5 -5 -Coba l t  { "Co )us  a  d iagnos t i e  t r ucc r  us ing  pos i t r on  cn r i ss ion
tomography (PET). Dosimetry, pharmacokinetics, diagnostic efïècti i,eness
and clinical reievance in distinct neurological diseases were assessed using
correlation with clinical scores and image-fusion with structural imaging.
The experimental rationale of Co is based on the assumed mimicry of
Calcium (Ca), thus visualising Ca-related neuronal degeneration and inflam-
mation in hrain clamage.
Chapter I : Scope of the thesis
The rationale of the studies describeC in this thesis, is based on theoretical
consiCerations (chapter 2) and translatetl into clinical pilot studies (chapter
-J). The actual results oíthese pilot studies are crit ically discussed (chapter 4).
Chapter 2: General introduction
A histnrical reyíew of the use of Co as a haernatopoetic agent and beer-
additive is provided with emphasis on its many adverse side reactions. It is
concluded that Co in pharmacological concentrations is a marked cytotorie
and cirrdiotoxic compound (2. I ). The strong in vitro and the weak ln l i lo eli-
dence of Co-deposition reflecting Ca-accumulation is discussed. Uptake-
experiments in neurons, glial cells. and ieukocytes, reveal both similarit ies
and diÍïerences in the comparison of Co and Ca. Transport of both Co and Ca
is competitive and based on receptor-operated membrane Ca-channels.
Determination of the actual Co-uptake mechanism in clinical practice is noto-
riously difficult and may consist of both an intra- and an extravascular con-
tribution. The int{avascular Co-deposition is determined by bloodflow (neo-
capil larisation; iuxury perÍusion) and bloodvolume (secondary haemorrhage;
venous bloodpool). The extravascular contribution comprises gating through
receptor-operated Ca-channels, deposition of (protein-bound) Co via a dis-
rupted blood brain barrier (BBB) and infi ltration of Co-labelled leukocytes.
Both types of contribution are time-dependent and separate mechanisms may
coincide. The net result is relatively siow Co-uptake without wash-out, the
abil ity to penetrate intact BBB, uptake in inflamed and/or decaying tissue and
mininral Co-uptake in normal brain (2.2). The plasma-profi le of Co consrsts
of a soluble fiee Íiaction (about l07c of the total plasma Co), a fraction com-
plexed to proteins (both reversibly [Co'.-N] and irreversibly [Co'.-S]
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attached) and cell-bound Co (mainly leukocytes). The ssCo effective radiation
dose (ED) is 0.22 mSv MBq.' (8.0 mSv mCi'); the 5?Co ED is 0.34 mSv
MBq' (12.4 mSv mCi') (2.2). In contrast o other widely used unchelated
tracer such as (Gallium) 67-Ga, (Rubidium) 82-Rb and (Thallium) 201-Tl,
Co demonstrates only a delayed signal (ca 6 hours post-administration), pro-
duces a low background and shows uptake in cell-decay and inflammation.
Typically, Co (ir)reversibly binds to liver proteins (enzymes?) providing a
reservoir, possibly accounting for a steady plasma-Co concentration, for at
leastT2 hours (2.2).
Multiple Sclerosis (MS) is an auto-immune central nervous system (CNS)
inflammation resulting in multifocal demyelination and axonal loss. MS can
demonstrate different courses of disease with each course having its typical
contribution of inflammation and cell-decay. Severity of illness can be
expressed in clinical scales such as Kurtzke's Expanded Disability Status
Scale (EDSS) and Scripp's Neurological Rating Scale (NRS) (2.3). The CNS-
confined T-lymphocytes, activated in the peripheral blood, mediate the
inflammatory process, resulting in waxing and waning of lesions. The
cytokine 1-interferon (fIFN) activates Ca-influx in "pre-activated" T-lym-
phocytes, which in turn start to proliferate and infiltrate the CNS. ApaÍ from
Co entering decaying neurons, these IIFN activated T-lymphocytes may
accumulate Co and thus account for the inflammatory delivery-component of
Co-PET in MS (2.3). Magnetic Resonance Imaging (MRI) is the gold stan-
dard in neuro-imaging of MS. However, the lack of association between the
clinical course of MS and MRl-findings has been a major concern (the clini-
cal-radiological paradox). Due to difficulties in measuring clinical outcome
("primary outcome measure") in MS and the lack of specificity of MRI as a
surrogate outcome measure ("secondary outcome measure"), there is a need
for alternative (complementary) CNS-imaging techniques (2.3). Image-
fusion of Co-PET and MRI using an appropriate Statistical Parametric
Mapping (SPM) software-package may fill the gap and allow less extensive
and costly therapy-evaluation and patient-stratifi cation (2.3).
Cerebral infarction (stroke) is a multi-factorial disease classified by
mechanism and duration of ischemia, vascular anatomy and residual clinical
deficit. Transition from ischemia to infarction involves an "ischemic cascade"
with Ca fulfilling a central role. Any stroke therapy must be started within
3-6 hours post-stroke (the "therapeutic window") (2.4). Computed
Tomography (CT) and MRI are the gold standard for structural imaging.
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Spectroscopy (MRS). Angiography can be performed using conventional
X-ray techniques, spiral C'I '  or MR Angiography (MRA) (2.4). PET and
SPECT can demonstrate Ílow- and metabolism-related aberrations in stroke.
thus predicting (to a certain extent) functional recovery (2.4).
Traumutic Broin Injurv (TBI) can be classified by lesion pattern, t ime
course, and mechanism of injury. DiÍluse axonal injury and ischernic brain
damage are the most comrnon mechanisms of injury (apart from the prirnary
mechanical in-rpact): secondary brain damage (SBD) (2.5). Ca Íulf i ls a central
role in SBD, which is both a neurochemical and a clinical phenomenon. CT
and MRI are the gold standard in TBl-imaging. Both PET and SPECT have
predictive value in TBI. However, SPECT r-nay be more applicable than PET
considerin-u the logistical problems and the urgency of pathology (2.5).
Primury l:troín tumour,i are classified by cell type, rnalignancy and clinical
prognosis. Clinical features vary depending on location, cell type and tumour
-srade. Both CT and MRl are of value, but do not differentiate tumour from
oedema or distinguish fumour response from tumour pro-eression. More
recent techniques include MRS and optical imaging-modalit ies. Both PET
and SPECT are of great value in providing additional information towards
tumour grade, oedema versus tumour, radiation etl'ect versus recurrent
tumour etc.  (2.6) .
Chapter 3 : Original Reprints
Co-PET vt'us studied:
(3.1 ; 3.2) : in two srnall series of midclle-cerebral-urÍery, (ntcct) ,stroke-
patients in combination with CT and/or MRI using the Orgogozo mca-stroke
scale (on adrrission and discharge). Since the time interval between stroke-
onset and Co-PET was highly variable (0-14 days), the actual (t ime-depen-
dent) mechanism of Co-deposition wil l also vary considerably. Apart Í iom
the small series studied, this profound uncertainty about the interpretation of
results rnay explain our paradoxical results. Thus, Co-PET using unchelated
Co may not be an ideal tool for stroke-irnaging.
(3.3; 3.4): both in a small series of T,secontlcLrl 'progressive MS (SP-MS)
patients (and 7 controls) and in a series of 32 MS-patients comprising 8
patients in each MS-course (and 8 controls). Image fusion of PET (Íbre-
ground) and MRI (background) was used (SPM-95 software package);
Kurtzke's EDSS and Scripp's NRS were used as clinical impairment scales.
Most MRl-lesions could be retrieved as Co-PET lesions. Both studies con-
tirmed the si-cniÍlcant correlation between the mean number of lesions on Co-
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Plr'f oir ihc onc harirj arrd the progrcs-rion rate (IEDSS / year) of discasc on
ihe other. intei '-obsel'r 'er correlation u.'as signiÍicant in all crlurses erccpt thr'
R.R-coLrrsi:. Thc co-rccistration tcchi.riclLrc seems io be a l 'r-rnciarnental tr de-oÍï
i ' iet\\ 'ee i l sensitir itt, and speciticitV.
i-J.-t, l . in :a lE! patieuts demonstratinc ibcal Cer-upfaitc in good correlatior.r
u ith L: [,C-irndin-s:i r1n.l Íreuropsycholo-qical testing. Se nsitivity exterlc' led
i-.e.,,.rnr.l ih,- l ir i i i i l ir ions of structural imagin-u (C'I ': MRI).
i, l .ó) : in -i 7r7'i1;111''y ítnrit i ÍruttouÍ's demonstrating i lrn"enhar.rcing uptake
al' i i i incl i. i  lrecll,)t ic tuurour core . Hi:;topaiirological diagnosis was obtained by
biopsl' ,.rL resectioit Vrable turlrour'-t is-cue clici not shov,' Co-accunulation;
l - rp iake inr i ices in  iprobably)decaying t issue var icc l  l tc twcen 2.6 and 5.3.  MRI
anllrt,.r CT. irsed l ls strulciural inraging niocialitv. eroulcl not clearly delineate
t!i ircl '  oericma ol' ne-ci 't lsis Ír-o't-n tu:rrour isstte.
i-1.7) : it i ttntitr itokittaiits trnd i iosinteÍr' i  cif t-Co arici itCo were stuciiecl in rats
rrnr.i - l l-reaiÍiry volLinteers. Bascci on phainracokinetic data. radii it ion dose cal-
cLrl;rt ions accol'r i ing to the MIRDOSE 3 systcm arc prc-sentecl. The iiver ancl
thc biaclcler fetair) fhe hi-uhest fractierns of j iCo. respectivell ' . '50% ancl 40c/c ot
the aciminisrerecl dose. fhe ïr 'ee flaction "Co in the hurlulr plasrna is at
rn; r r imun' r  1 l%. Thc volun ' ie  o l ' the cent ia i  compart inent  (2.8 l i t les)  is  in  the
sanie ol'ciei-of nri lgnifr-rrie as the calcr-riated plasnra voluure (-1.0 i iu'es). Tlie
" f lo  c f f lc t i ' ' ' c  rac i ie t ion c lose (ED) is  0.22 rnSv MBq'  (8.0 mSv nrCi  ' )  wi t i r  a
hat t ' - i i Íè  of  18.-s  hoLrrs (Lr io iogical  hal t - - l i t 'e  37.6 hours) ;  the i rCo ED is
( i .3 .1 n iS. , '  MBclr  (12. : l  n tSv mCi ' )  u ' i th  a hal l - i i fè  of  270 c lays (bro logicai
hai i - l i Íè  37.h hor i rs  . t .
{ ' l tupt ar -l: ( iatt ersl I)i.t<'ussiurt
ïn Conch-rding renrarirs ancl f uture pelspectives the respectir, 'c corltribution
i;i ircr-i lonal dccay and inllainrnation to net Co-deposition is discLrssed (4. l).
lJoth Co-PEI 'ancl  Co-SPECT rr lay have great  c l in ica l  poteni ia l  in  nuclear
neLu'o-i ir. i leing. ,\part f iorn extenrling the present studics into larger paticnt
sc l ics ( \ lS.  TBI"  pr i rnar) 'bra in t l ln tours)  and enter ing new areas of  r r t ter 'est
(l) i-rnrcnti i l  oi thc Alzheiurer Tilpe; Acr-rte N4yocardial Infarction), thc qLlcst Íor
Co labeller-l inilanrnratory proteins and lcukocytes may open an acldit ional
Í ie  k !  o i ' research t :1 .  I ) .
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4.3 Samcnv:rtting
Dit proel'schlit i  bes,
tweewaaidig iadi'JnLtc
be hulp van P0siti 'cl"l
k inet ick.  d iagnost ischt
lucur0ltlgi sche zieiitcbe
verlrancl {e vinrlett tnct
rrct stt 'uciLlfele trecidr
rnentele achtcrgt'ctitt l  r
stclcle overeenkotltsl t l
ronirlc schacle cn ontst
gcbracht.
ÍIoofdstuk I : O,-erzit
Dc rat ionl ic  l 'an i re l
op een literatr-rr-rrstr-rCi,
proe Í'studics ( hool'clstLr
kr i t isc l i  besproken {ht l
Hooftlsíuk 2 : Algemt
Er woldt een histor
r, 'erleden) i i ls blsreclvt
bict'. ttrct naclrLtk oP ci
ciat Co in pirartt iacol
(2 .  l  ) .  F le t  i n  v i t r o  cn  t
latic rveergecft. u'orcl
i-rcLiÍ0nen. giiacellen t
velschil ttt:;sen Co en
t ie i 'en 
-ucbascerd oP t
ber'vi!zen van het uer'I
is  r , r i tgesproken Ino
waaischijnli. j l i  uit zo
intravasculirire Co-de
capi iar isat ie :  " lurur \
\ . ,cneLrze b loeclpool l ,
,qcstl lurde Ca-kanaler
bloed hcrsenbarrière
